status: 200
content-location: http://rest.kegg.jp/get/path:map05169
server: Apache
date: Wed, 15 Oct 2014 14:59:05 GMT
content-type: text/plain

ENTRY       map05169                    Pathway
NAME        Epstein-Barr virus infection
DESCRIPTION Epstein-Barr virus (EBV) is a ubiquitous human herpesvirus that is associated with oncogenesis. EBV infection to primary human B lymphocytes leads to induction of EBV-specific HLA-restricted cytotoxic T cells, causing infectious mononucleosis during adolescence. Primary infection with EBV is followed by latent infection in which the reservoir B cells are immortalized. EBV tumorigenic potential in Burkitt lymphoma, nasopharyngeal carcinoma, Hodgkin lymphoma, and post-transplant B cell lymphomas has been well-documented. Distinct forms of EBV latency and patterns of latent gene expression can contribute to the different tumours.
CLASS       Human Diseases; Infectious diseases
PATHWAY_MAP map05169  Epstein-Barr virus infection
DISEASE     H00367  Infectious mononucleosis
REFERENCE   
  AUTHORS   Kieff E, Rickinson AB.
  TITLE     Epstein-Barr virus and its replication.
  JOURNAL   Fields Virology. New York, Lippincott-Raven
REFERENCE   PMID:15510157
  AUTHORS   Young LS, Rickinson AB.
  TITLE     Epstein-Barr virus: 40 years on.
  JOURNAL   Nat Rev Cancer 4:757-68 (2004)
REFERENCE   PMID:12910248
  AUTHORS   Young LS, Murray PG
  TITLE     Epstein-Barr virus and oncogenesis: from latent genes to tumours.
  JOURNAL   Oncogene 22:5108-21 (2003)
REFERENCE   PMID:10666279
  AUTHORS   Haan KM, Kwok WW, Longnecker R, Speck P
  TITLE     Epstein-Barr virus entry utilizing HLA-DP or HLA-DQ as a coreceptor.
  JOURNAL   J Virol 74:2451-4 (2000)
REFERENCE   PMID:16352731
  AUTHORS   Knight JS, Sharma N, Robertson ES
  TITLE     Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.
  JOURNAL   Proc Natl Acad Sci U S A 102:18562-6 (2005)
REFERENCE   PMID:15542638
  AUTHORS   Knight JS, Sharma N, Kalman DE, Robertson ES
  TITLE     A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds  cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.
  JOURNAL   J Virol 78:12857-67 (2004)
REFERENCE   PMID:10891508
  AUTHORS   Cotter MA 2nd, Robertson ES
  TITLE     Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha.
  JOURNAL   Mol Cell Biol 20:5722-35 (2000)
REFERENCE   PMID:14576817
  AUTHORS   Eliopoulos AG, Caamano JH, Flavell J, Reynolds GM, Murray PG, Poyet JL, Young LS
  TITLE     Epstein-Barr virus-encoded latent infection membrane protein 1 regulates the processing of p100 NF-kappaB2 to p52 via an IKKgamma/NEMO-independent signalling  pathway.
  JOURNAL   Oncogene 22:7557-69 (2003)
REFERENCE   PMID:10683340
  AUTHORS   Ikeda M, Ikeda A, Longan LC, Longnecker R
  TITLE     The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
  JOURNAL   Virology 268:178-91 (2000)
REFERENCE   PMID:15021898
  AUTHORS   Masucci MG
  TITLE     Epstein-Barr virus oncogenesis and the ubiquitin-proteasome system.
  JOURNAL   Oncogene 23:2107-15 (2004)
REFERENCE   PMID:14673102
  AUTHORS   Luftig M, Prinarakis E, Yasui T, Tsichritzis T, Cahir-McFarland E, Inoue J, Nakano H, Mak TW, Yeh WC, Li X, Akira S, Suzuki N, Suzuki S, Mosialos G, Kieff E
  TITLE     Epstein-Barr virus latent membrane protein 1 activation of NF-kappaB through IRAK1 and TRAF6.
  JOURNAL   Proc Natl Acad Sci U S A 100:15595-600 (2003)
REFERENCE   PMID:16007144
  AUTHORS   Mainou BA, Everly DN Jr, Raab-Traub N
  TITLE     Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
  JOURNAL   Oncogene 24:6917-24 (2005)
REFERENCE   PMID:18786993
  AUTHORS   Young KA, Herbert AP, Barlow PN, Holers VM, Hannan JP
  TITLE     Molecular basis of the interaction between complement receptor type 2 (CR2/CD21)  and Epstein-Barr virus glycoprotein gp350.
  JOURNAL   J Virol 82:11217-27 (2008)
REFERENCE   PMID:17159145
  AUTHORS   Portal D, Rosendorff A, Kieff E
  TITLE     Epstein-Barr nuclear antigen leader protein coactivates transcription through interaction with histone deacetylase 4.
  JOURNAL   Proc Natl Acad Sci U S A 103:19278-83 (2006)
REFERENCE   PMID:21518914
  AUTHORS   Portal D, Zhao B, Calderwood MA, Sommermann T, Johannsen E, Kieff E
  TITLE     EBV nuclear antigen EBNALP dismisses transcription repressors NCoR and RBPJ from  enhancers and EBNA2 increases NCoR-deficient RBPJ DNA binding.
  JOURNAL   Proc Natl Acad Sci U S A 108:7808-13 (2011)
REFERENCE   PMID:10644367
  AUTHORS   Zhou S, Fujimuro M, Hsieh JJ, Chen L, Hayward SD
  TITLE     A role for SKIP in EBNA2 activation of CBF1-repressed promoters.
  JOURNAL   J Virol 74:1939-47 (2000)
REFERENCE   PMID:16603506
  AUTHORS   Brinkmann MM, Schulz TF
  TITLE     Regulation of intracellular signalling by the terminal membrane proteins of members of the Gammaherpesvirinae.
  JOURNAL   J Gen Virol 87:1047-74 (2006)
REFERENCE   PMID:18559925
  AUTHORS   Anderson LJ, Longnecker R
  TITLE     EBV LMP2A provides a surrogate pre-B cell receptor signal through constitutive activation of the ERK/MAPK pathway.
  JOURNAL   J Gen Virol 89:1563-8 (2008)
REFERENCE   PMID:1658397
  AUTHORS   Flemington EK, Goldfeld AE, Speck SH
  TITLE     Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis.
  JOURNAL   J Virol 65:7073-7 (1991)
REFERENCE   PMID:12438576
  AUTHORS   Mauser A, Saito S, Appella E, Anderson CW, Seaman WT, Kenney S
  TITLE     The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms.
  JOURNAL   J Virol 76:12503-12 (2002)
REFERENCE   PMID:19375142
  AUTHORS   Sato Y, Shirata N, Kudoh A, Iwahori S, Nakayama S, Murata T, Isomura H, Nishiyama Y, Tsurumi T
  TITLE     Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription.
  JOURNAL   Virology 388:204-11 (2009)
REFERENCE   PMID:7895172
  AUTHORS   Miller CL, Burkhardt AL, Lee JH, Stealey B, Longnecker R, Bolen JB, Kieff E
  TITLE     Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases.
  JOURNAL   Immunity 2:155-66 (1995)
REFERENCE   PMID:10400785
  AUTHORS   Boyle SM, Ruvolo V, Gupta AK, Swaminathan S
  TITLE     Association with the cellular export receptor CRM 1 mediates function and intracellular localization of Epstein-Barr virus SM protein, a regulator of gene  expression.
  JOURNAL   J Virol 73:6872-81 (1999)
REFERENCE   PMID:9565632
  AUTHORS   Callan MF, Tan L, Annels N, Ogg GS, Wilson JD, O'Callaghan CA, Steven N, McMichael AJ, Rickinson AB
  TITLE     Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus In vivo.
  JOURNAL   J Exp Med 187:1395-402 (1998)
REFERENCE   
  AUTHORS   Isobe Y.
  TITLE     EB virus and oncogenesis. [Japanese]
  JOURNAL   Genomu Igaku. Tokyo, Medical Review Co. Ltd.
KO_PATHWAY  ko05169
///
